VI
Veradermics, Inc
SEC filingOther Health Care · New Haven, CT
Amount raised$30Msold at filing
Total offering$30M
Investors in the raise2count reported to the SEC
FiledMay 15, 2026first sale May 1, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
PATRICK ENRIGHTDirector
DAVID FRIEDMANDirector
JOHN CHILDSDirector
JANE GRANT-KELSDirector
VLADIMIR CORICDirector
MICHAEL GRECOExecutive Officer
REID WALDMANExecutive Officer, Director
KATARINA PANCEDirector
MARK NEUMANNExecutive Officer
DOMINIC CARRANOExecutive Officer
TIM DURSOExecutive Officer
Executive officers, directors and promoters as listed on the Form D.